Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to find the best treatment for obstructed gastric carcinoma in gastric cancer patients. It will include all patients with obstructed gastric cancer with different ages and sex who consented to share in the trial. The main question is what is the better for management for obstructed gastric cancer; palliative resection or palliative bypass? We hypothesized that resection is better. patients will be divided into two groups. the primary outcome measure will be the relief of obstruction
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I: obstructed gastric cancer patients | Active Comparator | patients presented with emergency gastric obstruction |
|
| Group II: obstructed gastric cancer patients | Active Comparator | patients presented with emergency gastric obstruction |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| palliative gastric resection | Procedure | distal, subtotal or total gastrectomy with gastro-jejunostomy or eosphago-jejunostomy will be done |
|
| Measure | Description | Time Frame |
|---|---|---|
| upper gastrointestinal symptoms | upper gastrointestinal symptoms will be evaluated after surgery by Rhodes Index questionnaire. It is a validated, self-report instrument used to measure the intensity, frequency, and distress of upper gastrointestinal symptoms. The scale measures three main areas: nausea (frequency, duration, distress), vomiting (amount, frequency, distress), and retching (frequency, distress). It utilizes a 5-point Likert scale (0-4) to quantify the severity of these symptoms. 0 is the least amount of distress and 4 is the most distress. | from one day to two weeks after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| anastmotic leak | anastmotic site leakage will be assessed by abnormal discharge in the drain calculated in cc. | from day one to two weeks after surgery. |
| ICU admission | the need of ICU admission will be evaluated by (yes or No) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Reham Zakaria, M.D | Zagazig University, Egypt | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| faculty of medicine, Zagazig University | Zagazig | Sharqia Province | 44519 | Egypt |
data will be available on demand by contacting the principle investigator
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| palliative bypass | Procedure | palliative gastro-jejunostomy or eosphago-jejunostomy will be done |
|
| from day one to two weeks after surgery |
| wound infection | wound infection will be identified by presence of pus in the dressing and positive culture and sensitivity test | from day one to one month after surgery |
| mortality | follow up of patient after surgery (died or not) | from one day to one month after surgery |
| D004066 |
| Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |